Recently, it has been found that m6A modification of TPM1 can promote the therapeutic efficacy of prostate cancer by mediating m6A modification [30], which affects the expression level of mRNA by affecting its shearing and translation [31]. The gene discussed is TPM1; the disease is prostate cancer.